Overview
Portfolio
More
Junipervc
Invests in category‑creating companies enabled by breakthroughs in biology, engineering, and computation to drive the bioindustrial revolution.
Portfolio
21+
Employees
5+
Founded
N/A
AUM
≈ $10.6M
Investment focus
Stages
No stages listed
Industries
No industries listedFund details
Funds
Fund I
Vintage 2024 • $10.6M
Sources
Junipervc
Invests in category‑creating companies enabled by breakthroughs in biology, engineering, and computation to drive the bioindustrial revolution.
Portfolio
21+
Employees
5+
Founded
N/A
AUM
≈ $10.6M
Funds
Fund I · Vintage 2024 • $10.6M
Showing 20 of 20 matched portfolio companies
Alta designs and manufactures next‑generation mineral separation technology for the mining and mineral processing sector. Their equipment and associated software improve ore recovery rates while reducing energy consumption, targeting operators seeking higher efficiency and lower operating costs. The company generates revenue through the sale of hardware systems, licensing of proprietary separation algorithms, and ongoing service contracts.
Funding: $5.2M
Rough estimate of the amount of funding raised
Funding: $5.2M
Rough estimate of the amount of funding raised
Anthology generates diverse, designer genomes by combining genetic parts across species boundaries to create novel biological capabilities. This technology enables the scalable and efficient production of functional proteins for human nutrition, improved animal health solutions, and carbon-neutral bioproduction from waste feedstocks. The resulting designer genomes maximize the practical impact of biology in addressing major global challenges.
Funding: $100.0K
Rough estimate of the amount of funding raised
Funding: $100.0K
Rough estimate of the amount of funding raised
Aralez Bio utilizes engineered enzymes to produce noncanonical amino acids, which are essential building blocks for peptide drugs, in a sustainable and cost-effective manner. This approach significantly reduces manufacturing time and costs, addressing the challenges of traditional amino acid production that often leads to long lead times and supply chain uncertainties.
Funding: $22.0M
Rough estimate of the amount of funding raised
Funding: $22.0M
Rough estimate of the amount of funding raised
Cache DNA develops next-generation biopreservation technologies to support breakthroughs in the life sciences. The company focuses on storing biomolecules at unprecedented scales, moving beyond traditional freezer storage methods. This advanced preservation supports high-quality biospecimens necessary for clinical research, assay development, and personalized therapies.
This company utilizes natural fermentation to cultivate premium, contaminant-free cocoa from selected cacao cells. Their process yields authentic chocolate flavor while ensuring stability and year-round production independent of traditional farming risks. The resulting cocoa is purer and supports forest-friendly, climate-clever sourcing for the food industry.
Funding: $9.0M
Rough estimate of the amount of funding raised
Funding: $9.0M
Rough estimate of the amount of funding raised
Copernic designs novel heterogeneous catalysts for zero-carbon fuels and chemicals, leveraging scientific computing tools to accelerate development. The company focuses initially on reducing the cost of zero-carbon ammonia production for fertilizers and maritime energy applications. Their solutions are engineered to be economic, rapidly scaleable, and compatible with existing chemical industry infrastructure.
Opeator is a fermentation technology company that utilizes an anaerobic process to enhance the efficiency and scalability of industrial fermentation. By enabling extended fermentation runs and employing low-cost bioreactors, the company improves process robustness and reduces operational costs for various industries.
Funding: $2.6M
Rough estimate of the amount of funding raised
Funding: $2.6M
Rough estimate of the amount of funding raised
This company converts diverse waste biomass feedstocks into fermentable sugars and chemical intermediates using a proprietary, feedstock-agnostic process. Their technology achieves high sugar recovery rates while utilizing commercially available equipment, reducing capital expenditure for biomanufacturing. The resulting products support the production of synthetic aviation fuels and cost-competitive chemicals, enhancing supply chain resilience.
This startup develops consumer products that utilize molecular and biological science to enhance healthspan and wellbeing through preventative health solutions. By providing accessible and effective tools, the company empowers individuals to take control of their health and longevity.
The startup manufactures biobased polyurethane to replace conventional plastics, providing sustainable coatings and adhesives specifically for the fashion and outdoor gear industries. This approach enables clients to eliminate harmful chemicals from their supply chains, promoting environmental safety and compliance.
Uses synthetic biology to engineer plant seeds that eliminate bottleneck enzymes in photosynthesis, significantly increasing plant productivity. This technology addresses the limitations of current agricultural yields, providing more food, fiber, and fuel while supporting climate change mitigation and land preservation efforts.
PrismBio utilizes proprietary biotechnology and microbial fermentation to produce a full spectrum of renewable, sustainable natural colorants. This platform delivers stable protein-pigment based colors for applications spanning food, personal care, and industrial markets. The company also offers ColorSwitch technology enabling on-product branding and messaging through laser-activated color changes.
Quorum Bio engineers precision biologics that enhance the crop microbiome to improve nutrient acquisition and stress tolerance, enabling farmers to reduce chemical fertilizer use by up to 50%. Their technology addresses the challenges of climate change by promoting crop resilience against drought and facilitating carbon sequestration in soils.
ScienceMachine develops specialized AI agents to automate complex, end-to-end research and development workflows for biomedical data analysis. These agents integrate deeply with existing tools to process raw laboratory data and generate final reports reliably and quickly. The platform offers tailored automation, transparency, and enterprise-grade security to enhance research efficiency and reproducibility.
Tabulous offers an AI‑enhanced electronic lab notebook combined with a laboratory information management system that centralizes protocol documentation, raw data capture, and analysis in a single web platform. The integrated AI tools automatically process experimental results and provide searchable, collaborative workspaces, helping biotech research teams improve reproducibility and accelerate insight generation.
Transition Biomining utilizes microbial communities to enhance copper extraction in heap leaching operations. Their data-driven biological solutions increase extraction efficiency, addressing the need for sustainable mining practices.
Trilobio provides an accessible platform for full laboratory automation, integrating robotics, modular tools, and intuitive software for biological experimentation. This system enables researchers to design and execute complex protocols quickly without extensive coding or calibration. The platform delivers precise, reproducible results while allowing labs to scale capacity affordably by connecting modular components.
10+
500+Approximate amount of employees
Funding: $3.0M
Rough estimate of the amount of funding raised
Funding: $3.0M
Rough estimate of the amount of funding raised
This startup develops a sustainable protein source derived from seaweed, providing a nutritious alternative to traditional animal-based proteins. By enabling seaweed farmers to produce a scalable and humane protein option, the company addresses the environmental impact of livestock farming and the demand for cruelty-free food sources.
Funding: $7.9M
Rough estimate of the amount of funding raised
Funding: $7.9M
Rough estimate of the amount of funding raised
ValleyDAO is a decentralized science platform that uses token‑driven funding and community governance to finance and accelerate climate‑focused biotechnology projects. It provides rapid grants of up to $200 k, mentorship, and access to a global network of researchers, investors, and tech‑transfer experts to move synthetic biology innovations from proof‑of‑concept to commercial scale.
Wildmicrobes uses synthetic biology to discover and engineer thousands of untapped microbial species from wild environments, creating production strains that synthesize high‑performance ingredients such as emulsifiers, vitamins, and industrial chemicals. Their high‑throughput genomics and bioinformatics pipeline identifies native biosynthetic pathways that reduce raw‑material costs and enable novel molecular functionalities, allowing ingredient manufacturers and specialty chemical producers to replace conventional inputs with renewable, bio‑derived alternatives.
Funding: $3.3M
Rough estimate of the amount of funding raised
Funding: $3.3M
Rough estimate of the amount of funding raised
Showing 1 of 1 unmatched portfolio company